Flotetuzumab for the Treatment of Relapsed or Refractory Advanced CD123-Positive Hematological Malignancies
City of Hope Medical Center
City of Hope Medical Center
Fred Hutchinson Cancer Center
Stemline Therapeutics, Inc.
Xencor, Inc.
Fred Hutchinson Cancer Center
Mayo Clinic
University of Texas Southwestern Medical Center
M.D. Anderson Cancer Center
Centre Hospitalier Universitaire de Besancon
National Cancer Institute (NCI)